NIH wants to end bad data

Share this article:

The NIH is cracking down on bad data. The US agency announced in Nature that the research field is plagued by data that cannot be replicated, and points the finger not at fraud, but at poor training and the wrong publishing incentives, among other factors.

To correct this problem, the NIH said it is developing training modules that should increase “reproducibility and transparency of research findings.” The NIH also wants to put pressure on academic institutions to demand more of research, and says the current focus on big-name journals and budgetary pressures “encourages rapid submission of research findings to the detriment of careful replication” and says it may rework its NIH grant applications to better define the role each applicant played in the study, among other changes.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.